Brief: Peer Reviewed Study Demonstrates MIMEDX's PURION® Processed Placental Allografts Outperforms Standard of Care in Select Mohs Defect Reconstructions
Nov 17 (Reuters) - MiMedx Group Inc MDXG.O :
* PEER REVIEWED STUDY DEMONSTRATES MIMEDX DEHYDRATED HUMAN
AMNION
CHORION MEMBRANE (DHACM) OUTPERFORMS STANDARD OF CARE IN SELECT
MOHS DEFECT RECONSTRUCTIONS
Source text for Eikon: ID:nGNXblR5t8
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates